No Pivot, No Turning Point, No Bottom

Mike RothschildLeave a comment

It was “an inflection point,” The New York Times declared in a devastating assessment of Donald Trump’s status.

Columnist Nate Cohn wrote that Republican “elites quickly moved to condemn [Trump’s] comments,” and that “his support will erode as the tone of coverage shifts from publicizing his anti-establishment and anti-immigration views … to reflecting the chorus of Republican criticism of his most outrageous comments.”

Trump’s shocking remarks “were nothing less than an invitation for the rest of the Republican Party to begin their long-awaited offensive.” Cohn concluded. “Nearly all [Republicans] have incentives to pile on, and Mr. Trump — without a deep base of support and with few party allies — will struggle to hold on.”

The comments in question had nothing to do with the Nazi riot in Charlottesville this weekend. If fact, they had nothing to do with anything Trump has said while President, or even while he was the presumptive nominee.

Read More »

Advertisements

The Confederacy Invaded the U.S. A Century Later, The U.S. Couldn’t Stop Paying Tribute To It

Mike RothschildLeave a comment

As Confederate monuments go, it’s not flashy or famous. It’s not even that big. A slab of chipped granite surrounding about 30 graves, the monument reads

“In memory of the soldiers of the Confederate States Army who have died or may die on the Pacific coast, Erected by the Confederate Monument Association.  Lord God of Hosts, be with us yet. Lest we forget – lest we forget. 1861-1865″

This small, mostly forgotten monument doesn’t sit in a cemetery in deep south Richmond, Atlanta, or Mobile. It’s not even on a battlefield memorial.

It’s in the Hollywood Forever Cemetery, right in the center of the godless liberal orgy capital of Los Angeles, California.

Read More »

James Alex Fields Jr., Heather Heyer, and the History of Nazi Street Brawling

Mike Rothschild1 Comment

On May 7th, 1945, around 6 P.M., Private First Class Charles Havlat was on patrol near Volary, Czechoslovakia with fellow soldiers of the Fifth Infantry Division. He was manning a machine gun in a jeep driven by the Lieutenant leading the unit.

His squad was ambushed, and during a “brief, but intense skirmish,” Havalt was shot through the head and killed. The shooting ended only because both sides were informed that hours earlier, Nazi Germany had signed an instrument of surrender. It was due to take effect at midnight of the next day, and when it did, World War II in Europe was over.

Killed in a completely unnecessary action, PFC Havlat is generally regarded as the last American to die at the hands of Nazi aggression.

Or at least he was until this weekend.

Read More »

Here’s What’s (Probably) Going to Happen with North Korea

Mike RothschildLeave a comment

August is hot. Humid, bedraggling, motivation-sapping hot. It’s so hot that Neil Diamond has a famous live album that’s literally called “Hot August Night.”

But what’s hotter than Neil Diamond busting out “I Am, I Said” for an amphitheater full of sweaty boomers?

 

 

 

 

 

 

 

A nuclear bomb going off over your head and turning you into atoms. That’s hot.

Obviously, the sabre-rattling between the U.S. and North Korea over Kim Jong Un’s nuclear ambitions has people nervous. Panicking, even. News broke last week that the Kim regime might be much closer to developing a nuclear warhead that can fit on a missile than anyone believed. He’s testing ICBM’s that could hit well into the U.S., and making grave threats about firing missiles at Guam and”mercilessly wiping out” his enemies.

Read More »

How to Spot a Bad Scientific Study

Mike RothschildLeave a comment

I wrote this for ATTN: and don’t feel like it got the love it deserved. I dove into how you can tell if a new scientific finding making the media all a-flutter is actually worth your time, or something to be discarded.

How do you do that? If you can, try to read the study’s abstract on PubMed. If it’s a medical or drug discovery, see if it was a well-designed study, using randomized controlled trials and a large sample size.

Also see what conflicts of interest and funders the researchers are involved with. And if you can’t find that, try to find the impact factor of the journal. Is it well-respected by its peers. or an open-access journal that takes advantage of scientists by charging them to publish?

All that and more, can be found here.